Aliases & Classifications for Ureteral Obstruction

About this section

Aliases & Descriptions for Ureteral Obstruction:

Name: Ureteral Obstruction 11 49 13

External Ids:

Disease Ontology11 DOID:5199
SNOMED-CT61 197807001
ICD9CM31 593.4

Summaries for Ureteral Obstruction

About this section
MalaCards based summary: Ureteral Obstruction is related to low compliance bladder and discitis. An important gene associated with Ureteral Obstruction is TGFB1 (Transforming Growth Factor Beta 1), and among its related pathways are Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics and Jak/STAT Signaling Pathway. Affiliated tissues include kidney, bone and endothelial, and related mouse phenotypes are adipose tissue and vision/eye.

Related Diseases for Ureteral Obstruction

About this section

Diseases related to Ureteral Obstruction via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 136)
idRelated DiseaseScoreTop Affiliating Genes
1low compliance bladder29.7IL10, NOS2, TGFB1
2discitis29.7AGTR1, CLU, TGFB1
3benign neonatal seizures10.5AQP2, BMP7, TGFB1
4renal fibrosis10.5
5bubonic plague10.5AGTR1, NOS2, TGFB1
6post-infectious myocarditis10.4AGTR1, AGTR2, TGFB1
7pulpitis10.4AQP2, SLC12A1, TGFB1
8kidney hypertrophy10.4AGTR1, AGTR2, TGFB1
9fatal infantile hypertrophic cardiomyopathy due to mitochondrial complex i deficiency10.4AGTR2, TGFB1
10variola minor10.3IL10, NOS2, TGFB1
11infiltrating lipoma10.3PTGS2, TP53
12benign struma ovarii10.3AQP2, BMP7, PTGS2, TGFB1
13atypical follicular adenoma10.3IL10, NOS2, TGFB1
14exocrine pancreatic insufficiency10.3AGTR1, EPO, TGFB1
15papillary cystadenocarcinoma10.3IL10, TGFB1
16spondylolysis10.2IL10, SLC12A1, SLC9A3
17xanthomatosis10.2IL10, PTGS2, TGFB1
18pancreatic somatostatinoma10.2CTNNB1, TGFB1, TP53
19congenital methemoglobinemia10.2AGTR1, TGFB1
20synostosis10.2PTGS2, TGFB1, TP53
21lobular neoplasia10.2CTNNB1, TGFB1, TP53
22lethal midline granuloma10.2IL10, NOS2, TGFB1
23perianal skin paget's disease10.2IL10, PTGS2, TGFB1
24gastrointestinal neuroendocrine tumor10.2CTNNB1, PTGS2, TP53
25periapical granuloma10.2CTNNB1, PTGS2, TP53
26orbital lymphangioma10.2IL10, TGFB1, TP53
27ectopia lentis, familial10.2AGTR1, BMP6, TGFB1
28male reproductive organ benign neoplasm10.2CTNNB1, PTGS2, TP53
29congenital hypomyelination neuropathy10.1CTNNB1, PTGS2, TP53
30arrhythmogenic right ventricular cardiomyopathy10.1CTNNB1, PTGS2, TP53
31dysostosis10.1CTNNB1, TGFB1, TP53
32arteritic anterior ischemic optic neuropathy10.1CTNNB1, PTGS2, TP53
33hydronephrosis10.1
34retroperitoneal fibrosis10.1
35pediatric supratentorial ependymoma10.1IL10, PTGS2, TP53
36hypertension, essential10.1AGTR1, AGTR2, NOS2, SLC12A1
37paroxysmal nocturnal hemoglobinuria10.1CTNNB1, TGFB1, TP53
38plasmacytoma10.1CTNNB1, PTGS2, TP53
39plasma protein metabolism disease10.0CTNNB1, PTGS2, TGFB1, TP53
40anuria10.0
41gallbladder papillomatosis10.0CTNNB1, PTGS2, TGFB1, TP53
42villous adenoma10.0CTNNB1, PTGS2, TGFB1, TP53
43aneurysm10.0
44brown-vialetto-van laere syndrome10.0CTNNB1, PTGS2, TP53
45vesicoureteral reflux10.0
46anus disease10.0CTNNB1, PTGS2, TP53
47eosinophilic gastritis9.9IL10, NOS2, PTGS2, TP53
48endometriosis9.9
49lipomatosis9.9
50pelvic lipomatosis9.9

Graphical network of the top 20 diseases related to Ureteral Obstruction:



Diseases related to ureteral obstruction

Symptoms for Ureteral Obstruction

About this section

Drugs & Therapeutics for Ureteral Obstruction

About this section

Drugs for Ureteral Obstruction (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 66)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
SilodosinapprovedPhase 422160970-54-7
Synonyms:
KAD 3213
 
KMD 3213
Rapaflo
Urief
2
Sevofluraneapproved, vet_approvedPhase 447928523-86-65206
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
28523-86-6
AC-15484
AC1L1JU0
BRN 2041023
Bax 3084
C009250
C07520
C4H3F7O
CHEBI:9130
CHEMBL1200694
CID5206
D00547
DB01236
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
I14-13357
LS-67851
MR6S4
 
MR_6S4
MolPort-001-775-746
NCGC00167421-01
PC4681
Sevofluran
Sevoflurane
Sevoflurane (JAN/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
UNII-38LVP0K73A
Ultane
Ultane (TN)
ZINC01530810
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
sevoflurane
3
DesfluraneapprovedPhase 414357041-67-542113
Synonyms:
(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane
1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane
2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane
57041-67-5
AC1L274J
AC1Q4ICY
C07519
C3H2F6O
CHEBI:4445
CHEMBL1200733
CID42113
D00546
DB01189
DESFLURANE
Desflurane
 
Desflurane (JAN/USP/INN)
Desflurane [USAN:INN]
Desflurano
Desflurano [INN-Spanish]
Desfluranum
Desfluranum [INN-Latin]
Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
I 653
I-653
I653
LS-65505
MolPort-001-776-387
PC6781E
Suprane
Suprane (TN)
UNII-CRS35BZ94Q
difluoromethyl 1,2,2,2-tetrafluoroethyl ether
r-e 236ea1
4
Tamsulosinapproved, investigationalPhase 4, Phase 3157106133-20-4129211
Synonyms:
(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
106133-20-4
5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide
5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide
5-[2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide
5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide
5-{(2R)-2-[(2-{[2-(ethyloxy)phenyl]oxy}ethyl)amino]propyl}-2-(methyloxy)benzenesulfonamide
AC1L2V76
BIDD:GT0261
C07124
C20H28N2O5S
CHEBI:9398
CHEMBL836
CID129211
D08560
DB00706
FT-0082894
Flomax
Flomax (TN)
 
Flowmax
HMS2090P15
Harnal
LS-31578
MolPort-003-850-388
NCGC00167442-01
STK626950
TAMSULOSIN
Tamsolusin
Tamsulon
Tamsulon (TN)
Tamsulosin
Tamsulosin (INN)
Tamsulosin [INN:BAN]
Tamsulosina
Tamsulosina [INN-Spanish]
Tamsulosine
Tamsulosine [INN-French]
Tamsulosinum
Tamsulosinum [INN-Latin]
UNII-G3P28OML5I
YM-617
5
Isofluraneapproved, vet_approvedPhase 416526675-46-73763
Synonyms:
1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether
1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether
2-Chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane
2-chloro-2-difluoromethoxy-1,1,1-trifluoroethane
26675-46-7
AC-154802
AC1L1GNN
AErrane (Veterinary)
Aerrane
BRN 1852087
C07518
CCRIS 3043
CHEBI:6015
CHEMBL1256
CID3763
Compound 469
D00545
D007530
DB00753
EINECS 247-897-7
Ethane
Ether, 1-chloro-2,2,2-trifluoroethyl difluoromethyl
 
Forane
Forane (TN)
Forene
I14-1303
IsoFlo
Isoflurane
Isoflurane (JP15/USP/INN)
Isoflurane [Anaesthetics, volatile]
Isoflurane [USAN:BAN:INN:JAN]
Isoflurane [USAN:INN:BAN:JAN]
Isoflurane [Usan:Ban:Inn:Jan]
Isoflurano
Isoflurano [INN-Spanish]
Isofluranum
Isofluranum [INN-Latin]
Jsp005223
LS-7462
MolPort-000-153-606
NCGC00181037-01
R-E 235dal
ST51041445
UNII-CYS9AKD70P
isoflurane
6
MirabegronapprovedPhase 4, Phase 289223673-61-8
Synonyms:
 
Myrbetriq
7
AcetaminophenapprovedPhase 4978103-90-21983
Synonyms:
4'-Hydroxyacetanilide
4'-hydroxyacetanilide
4-(Acetylamino)phenol
4-Acetamidophenol
4-Acetaminophenol
4-Hydroxyacetanilide
4-Hydroxyanilid kyseliny octove
4-acetamidophenol
A-Per
A.F. Anacin
AC1Q1KYJ
AC1Q1KYK
APAP
Abenol
Abensanil
Abrol
Abrolet
Acamol
Accu-Tap
Acenol
Acephen
Acertol
Aceta Elixir
Aceta Tablets
Acetaco
Acetagesic
Acetalgin
Acetaminofen
Acetaminophen
Acetaminophen Uniserts
Acetamol
Acetavance
Acetofen
Actamin
Actamin Extra
Actamin Super
Actifed Plus
Actimol
Actimol Chewable Tablets
Actimol Children'S Suspension
Actimol Infants' Suspension
Actimol Junior Strength Caplets
Actron
Afebrin
Afebryl
Aferadol
Algesidal
Algina
Algomol
Algotropyl
Allay
Alpiny
Alpinyl
Alvedon
Amadil
Aminofen
Aminofen Max
Anacin
Anacin 3
Anacin-3
Anacin-3 Extra Strength
Anadin dla dzieci
Anaflon
Analter
Anapap
Andox
Anelix
Anexsia
Anexsia 10/660
Anexsia 5/325
Anexsia 7.5/325
Anexsia 7.5/650
Anhiba
Anoquan
Anti-Algos
Antidol
Anuphen
Apacet
Apacet Capsules
Apacet Elixir
Apacet Extra Strength Caplets
Apacet Extra Strength Tablets
Apacet Regular Strength Tablets
Apadon
Apamid
Apamide
Apitrelal
Apo-Acetaminophen
Arfen
Arthralgen
Asetam
Asomal
Aspac
Aspirin Free Anacin Maximum Strength Caplets
Aspirin Free Anacin Maximum Strength Gel Caplets
Aspirin Free Anacin Maximum Strength Tablets
Aspirin-Free Anacin
Aspirin-Free Excedrin Caplets
Asplin
Atasol
Atasol Caplets
Atasol Drops
Atasol Forte Caplets
Atasol Forte Tablets
Atasol Oral Solution
Atasol Tablets
Atralidon
Babikan
Bacetamol
Bancap
Bancap Hc
Banesin
Bayer Select
Bayer Select Allergy-Sinus
Bayer Select Head Cold
Bayer Select Headache Pain
Bayer Select Maximum Strength Headache Pain Relief Formula
Bayer Select Menstrual Multi-Symptom
Bayer Select Sinus Pain Relief
Ben-u-ron
Benmyo
Bickie-mol
Biocetamol
Bucet
Butalbital
Butapap
CCRIS 3
CHEBI:46195
Cadafen
Calapol
Calmanticold
Calonal
Calpol
Capital
Capital with Codeine
Captin
Causalon
Cefalex
Cetadol
Children'S Acetaminophen Elixir Drops
Children'S Acetaminophen Oral Solution
Children'S Tylenol Chewable
Claradol Codeine
Clixodyne
Co-Gesic
Cod-Acamol Forte
Codabrol
Codalgin
Codapane
Codicet
Codisal
Codisal Forte
Codoliprane
Codral Pain Relief
Cofamol
Conacetol
Contac Cough & Sore Throat Formula
Contra-Schmerz P
Coricidin
Coricidin D
Coricidin Sinus
Cosutone
Croix Blanche
Cuponol
Curadon
Curpol
Custodial
D oliprane
Dafalgan
Dapa
Dapa X-S
Darocet
Darvocet
Darvocet-N 50
Datril
Datril Extra-Strength
Daygrip
Demilets
Deminofen
Democyl
Demogripal
Desfebre
Dhamol
Dhc Plus
Dial-a-gesic
Dial-alpha-gesic
Dimindol
Dirox
Disprol
Dol-Stop
Dolcor
Dolefin
Dolegrippin
Dolene AP-65
Dolene Ap-65
Dolgesic
Doliprane
Dolko
Dolofugin
Doloreduct
Dolorfug
Dolorol Forte
Dolorstop
Dolotec
Dolprone
Dorocoff
Dresan
Dristan Cold No Drowsiness
Dristancito
Drixoral Plus
Duaneo
Dularin
Duorol
Duracetamol
Duradyne Dhc
Durapan
Dymadon
Dymadon Co
Dymadon Forte
Dypap
Ecosetol
Elixodyne
Empracet
Endecon
Enelfa
Eneril
Esgic
Esgic-Plus
Eu-Med
Excedrin
Excedrin Caplets
Excedrin Extra Strength Caplets
Excipain
Exdol
Exdol Strong
Fanalgic
Farmadol
Febranine
Febrectal
Febrectol
Febrex
Febricet
Febridol
Febrilix
Febrin
Febrinol
Febro-Gesic
Febrolin
Femcet
Fendon
Fensum
Fepanil
Fever All
Feverall
Feverall Junior Strength
Feverall Sprinkle Caps Junior Strength
Fevor
Finimal
Finiweh
Fioricet
Fluparmol
Fortalidon P
Freka-cetamol
Gattaphen T
Gelocatil
Geluprane
Genapap
Genapap Children'S Elixir
Genapap Children'S Tablets
Genapap Extra Strength Caplets
Genapap Extra Strength Tablets
Genapap Regular Strength Tablets
Genebs
Genebs Extra Strength Caplets
Genebs Regular Strength Tablets
Genebs X-Tra
Geralgine-P
Gripin Bebe
Grippostad
Gynospasmine
Hedex
Helon N
Homoolan
Hy-Phen
Hycomine Compound
Hydrocet
Ildamol
Inalgex
Infadrops
Infants' Feverall
Influbene N
Injectapap
Intensin
Janupap
Jin Gang
Junior Disprol
KBio1_000660
Kataprin
Kinder Finimal
Korum
Kratofin simplex
L024125
Labamol
Lekadol
Lemgrip
Lemsip
Lestemp
Liqiprine
Liquagesic
Liquigesic Co
Liquiprin
Liquiprin Children'S Elixir
Liquiprin Infants" Drops
Lonarid
Lonarid Mono
Lorcet-Hd
Lortab
Lupocet
Lyteca
Lyteca Syrup
Magnidol
Malex N
Malgis
Malidens
Maxadol
Medigesic Plus
Medinol Paediatric
Medocodene
Melabon Infantil
Mexalen
Midol Maximum Strength
Midol PM Night Time Formula
Midol Regular Strength
Midol Teen Formula
Migraleve Yellow
Minafen
Minoset
Miralgin
Momentum
Mono Praecimed
 
Multin
N-(4-Hydroxyphenyl)acetamide
N-Acetyl-4-aminophenol
N-Acetyl-p-aminophenol
N-acetyl-p-aminophenol
NAPA
NCX 701
NEBS
NSC3991
Naldegesic
Napafen
Napap
Naprinol
Nealgyl
Nebs
Neo-Fepramol
NeoCitran
Neodol
Neodolito
Neopap
Neotrend
Neuridon
New Cortal for Children
NilnOcen
Nina
No-Febril
Nobedon
Nodolex
Noral
Norcet
Norco
O-Acetaminophenol
Ofirmev
Oltyl
Oralgan
Oraphen-PD
Ortensan
Oxycet
Oxycocet
Oxycodone 2.5/Apap 500
Oxycodone 5/Apap 500
PCM Paracetamol Lichtenstein
Paceco
Pacemo
Pacemol
Pacet
Pacimol
Paedialgon
Paedol
Painex
Paldesic
Pamol
Panacete
Panadeine
Panadeine Co
Panadiene
Panado-Co
Panado-Co Caplets
Panadol
Panadol Extra Strength
Panadol Junior Strength Caplets
Panadol Maximum Strength Caplets
Panadol Maximum Strength Tablets
Panale ve
Panaleve
Panamax
Panasorb
Panasorbe
Panets
Panex
Panodil
Panofen
Pantalgin
Papa-Deine
Papa-Deine #3
Papa-Deine #4
Para-Suppo
Para-Tabs
Paracemol
Paracenol
Paracet
Paracetamol
Paracetamol AL
Paracetamol Antipanin P
Paracetamol BC
Paracetamol Basics
Paracetamol DC
Paracetamol Dr. Schmidgall
Paracetamol Fecofar
Paracetamol Genericon
Paracetamol Hanseler
Paracetamol Harkley
Paracetamol Heumann
Paracetamol Hexal
Paracetamol Italfarmaco
Paracetamol Nycomed
Paracetamol PB
Paracetamol Raffo
Paracetamol Ratiopharm
Paracetamol Rosch
Paracetamol Saar
Paracetamol SmithKline Beecham
Paracetamol Stada
Paracetamol Winthrop
Paracetamol von ct
Paracetamole
Paracetamolo
Paracetamolum
Paracetanol
Paracetol
Paracin
Paracod
Paracodol
Paracétamol
Parador
Paradrops
Parakapton
Parake
Paralen
Paralief
Paralink
Paralyoc
Paramol
Paramolan
Paranox
Parapan
Parasedol
Parasin
Paraspen
Parcetol
Parelan
Parmol
Parogal
Paroma
Pasolind
Pasolind N
Pe-Tam
Pediapirin
Pediatrix
Pedric
Percocet
Percocet-5
Percocet-Demi
Percogesic with Codeine
Perdolan Mono
Perfalgan
Phenaphen
Phenaphen Caplets
Phenaphen W/Codeine
Phendon
Phenipirin
Phogoglandin
Phrenilin
Phrenilin Forte
Pinex
Piramin
Pirinasol
Plicet
Polmofen
Predimol
Predualito
Prestwick_13
Prodol
Prompt
Prontina
Propacet
Propacet 100
Proval #3
Puernol
Pulmofen
Pyregesic-C
Pyrigesic
Pyrinazine
Pyromed
Quiet World
Redutemp
Reliv
Remedol
Rhinex D-Lay Tablets
Rivalgyl
Robigesic
Robitussin Night Relief
Rockamol Plus
Rounox
Roxicet
Roxicet 5/500
Roxilox
RubieMol
Rubophen
Rupemol
SK-Apap
SPBio_002836
Salzone
Sanicet
Sanicopyrine
Scanol
Scentalgyl
Scherzatabletten Rezeptur 534
Schmerzex
Sedalito
Sedapap
Semolacin
Servigesic
Seskamol
Setakop
Setamol
Setol
Sifenol
Sinaspril
Sine-Off Sinus Medicine Caplets
Sinedol
Sinmol
Sinubid
Snaplets-FR
Spalt N
Spalt fur die nacht
St Joseph Aspirin-Free
St Joseph Aspirin-Free for Children
St. Joseph Cold Tablets for Children
St. Joseph Fever Reducer
Stanback
Stopain
Sudafed Severe Cold Formula
Sudafed Sinus
Sunetheton
Supac
Supadol mono
Supofen
Suppap
Suppap-120
Suppap-325
Suppap-650
Supramol-M
Synalgos-Dc-A
TYL
Tabalgin
Tachiprina
Talacen
Tapanol
Tapanol Extra Strength Caplets
Tapanol Extra Strength Tablets
Tapar
Tavist Allergy/Sinus/Headache
Tazamol
Temlo
Tempanal
Tempra
Tempra Caplets
Tempra Chewable Tablets
Tempra D.S
Tempra Drops
Tempra Syrup
Tencon
Termacet
Termalgin
Termalgine
Termofren
TheraFlu
Tibinide
Tibizide
Tiffy
Tisin
Tisiodrazida
Titralgan
Tizide
Tocris-1706
Toximer P
Tralgon
Treupel N
Treupel mon
Treuphadol
Triad
Triaminic Sore Throat Formula
Triaprin
Tricoton
Tussapap
Ty lenol
Tycolet
Tylenol
Tylenol (TN)
Tylenol Allergy Sinus
Tylenol Arthritis Extended Relief
Tylenol Caplets
Tylenol Children'S Chewable Tablets
Tylenol Children'S Elixir
Tylenol Children'S Suspension Liquid
Tylenol Drops
Tylenol Elixir
Tylenol Extra Strength Adult Liquid Pain Reliever
Tylenol Extra Strength Caplets
Tylenol Extra Strength Gelcaps
Tylenol Extra Strength Tablets
Tylenol Gelcaps
Tylenol Infants Drops
Tylenol Infants" Suspension Drops
Tylenol Junior Strength Caplets
Tylenol Junior Strength Chewable Tablets
Tylenol Regular Strength Caplets
Tylenol Regular Strength Tablets
Tylenol Tablets
Tylex
Tylex CD
Tylol
Tylox
Tylox-325
Tymol
Ultracet
Upsanol
Utragin
Valadol
Valgesic
Valorin
Valorin Extra
Vanquish
Veralgina
Vermidon
Verpol
Viclor Richet
Vicodin
Vicodin Es
Vicodin Hp
Vips
Viruflu
Vivimed
Volpan
Wygesic
Zatinol
Zolben
acetaminofén
acétaminophène
alpha-Per
p-(Acetylamino)phenol
p-Acetamidophenol
p-Acetaminophenol
p-Acetylaminophenol
p-Hydroxyacetanilide
p-Hydroxyphenolacetamide
p-acetamidophenol
p-acetaminophenol
p-hydroxy-acetanilid
p-hydroxyacetanilide
p-hydroxyphenolacetamide
8Platelet Aggregation InhibitorsPhase 42419
9Adrenergic AgentsPhase 4, Phase 3, Phase 25140
10Peripheral Nervous System AgentsPhase 4, Phase 222776
11Central Nervous System DepressantsPhase 4, Phase 212806
12Adrenergic alpha-AntagonistsPhase 4, Phase 3727
13Adrenergic alpha-1 Receptor AntagonistsPhase 4, Phase 3470
14Adrenergic AntagonistsPhase 4, Phase 31535
15Neurotransmitter AgentsPhase 4, Phase 3, Phase 217734
16Anesthetics, InhalationPhase 4649
17Anesthetics, GeneralPhase 42787
18AnestheticsPhase 4, Phase 29001
19NarcoticsPhase 43486
20Analgesics, Non-NarcoticPhase 46260
21AntipyreticsPhase 41534
22Acetaminophen, hydrocodone drug combinationPhase 496
23Adrenergic AgonistsPhase 4, Phase 22877
24Adrenergic beta-3 Receptor AgonistsPhase 4, Phase 297
25AnalgesicsPhase 411287
26Adrenergic beta-AgonistsPhase 4, Phase 21640
27Calcium, DietaryPhase 45525
28Muscarinic AntagonistsPhase 41134
29Tolterodine tartratePhase 489124937-52-6
30Cholinergic AgentsPhase 43846
31Cholinergic AntagonistsPhase 41658
32
GemcitabineapprovedPhase 2, Phase 1197495058-81-460750
Synonyms:
103882-84-4
122111-03-9
2',2'-DiF-dC
2',2'-Difluoro-2'-deoxycytidine
2',2'-Difluorodeoxycytidine
2'-Deoxy-.beta.-D-2',2'-difluorocytidine
2'-Deoxy-2',2'-difluorocytidine
4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one
4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one
95058-81-4
AB1004842
AC1L1TUQ
C07650
CCRIS 8984
CHEBI:175901
CHEMBL888
CID60750
Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine
D02368
DB00441
DDFC
DFDC
DFdC
DFdCyd
Folfugem
GEO
Gamcitabine
GemLip
Gemcel
 
Gemcin
Gemcitabin
Gemcitabina
Gemcitabina [INN-Spanish]
Gemcitabine
Gemcitabine (USAN/INN)
Gemcitabine HCl
Gemcitabine hydrochloride
Gemcitabine stereoisomer
Gemcitabinum
Gemcitabinum [INN-Latin]
Gemtro
Gemzar
Gemzar (hydrochloride)
HMS2089P10
HSDB 7567
Inno-D07001
LS-59139
LY 188011
LY-188011
LY188011
NCGC00168784-01
NChemBio.2007.10-comp25
NSC 613327
NSC613327
TL8005979
UNII-B76N6SBZ8R
ZINC18279854
Zefei
gemcitabine
nchembio.573-comp7
nchembio.90-comp2
33
TriclosanapprovedPhase 2593380-34-55564
Synonyms:
112099-35-1
164325-69-3
2,4,4'-Trichloro-2'-hydroxy diphenyl ether
2,4,4'-Trichloro-2'-hydroxydiphenyl ether
2-Hydroxy-2',4,4'-trichlorodiphenyl Ether
261921-78-2
3380-34-5
5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL
5-Chloro-2-(2,4-dichloro-phenoxy)-phenol
524190_ALDRICH
72779_FLUKA
72779_SIGMA
88032-08-0
AC-10667
AC1L1KMN
Aquasept
BRN 2057142
C12059
C12H7Cl3O2
CCRIS 9253
CH 3565
CH-3565
CHEBI:164200
CHEMBL849
CID5564
CPD0-1227
CPD000471847
Caswell No. 186A
Clearasil Daily Face Wash
Cliniclean
Cloxifenol
Cloxifenolum
D014260
D06226
DB08604
DP-300
Dermtek Brand of Triclosan
EINECS 222-182-2
EPA Pesticide Chemical Code 054901
Ether, 2'-hydroxy-2,4,4'-trichlorodiphenyl
GlaxoSmithKline Brand of Triclosan
HMS2093L17
HSDB 7194
I01-2897
 
IN1424
Irgasan
Irgasan DP 300
Irgasan DP300
Johnson & Johnson Brand of Triclosan
LS-67854
Lexol 300
MLS001066347
MLS001074876
MLS001335937
MLS001335938
Manusept
Microshield T
MolPort-003-666-702
NCGC00159417-02
NCGC00159417-03
NCGC00159417-04
Oxy Skin Wash
Pharmachem Brand of Triclosan
Procter & Gamble Brand of Triclosan
Reckitt Brand of Triclosan
S00100
SAM002554907
SBB058565
SMR000471847
SSL Brand of Triclosan
Sapoderm
Ster Zac Bath Concentrate
Ster-Zac Bath Concentrate
SterZac Bath Concentrate
Stri-Dex Cleansing Bar
Stri-Dex Face Wash
Stri-Dex cleansing bar (TN)
TCL
TL8002539
Trans Canaderm Brand of Triclosan
Triclosan
Triclosan (USP/INN)
Triclosan Pharmachem Brand
Triclosan Reckitt Brand
Triclosan [USAN:BAN:INN]
Triclosanum
Triclosanum [INN-Latin]
Trisan
UNII-4NM5039Y5X
34
Lidocaineapproved, vet_approvedPhase 21226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
35
Paclitaxelapproved, vet_approvedPhase 2275833069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nab-paclitaxel
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel
36Antibodies, MonoclonalPhase 2, Phase 13795
37ImmunoglobulinsPhase 2, Phase 16045
38Albumin-Bound PaclitaxelPhase 22757
39Pharmaceutical SolutionsPhase 27793
40AntibodiesPhase 2, Phase 16045
41Immunosuppressive AgentsPhase 2, Phase 112770
42Antiviral AgentsPhase 2, Phase 19732
43Antimetabolites, AntineoplasticPhase 2, Phase 17171
44Anti-Infective Agents, LocalPhase 21785
45AntimetabolitesPhase 2, Phase 111774
46Anti-Infective AgentsPhase 2, Phase 121402
47Sodium Channel BlockersPhase 21515
48Hypolipidemic AgentsPhase 22721
49
IodinePhase 25467553-56-2807
Synonyms:
I2
Iode
Iodine-molecule
 
Iodio
Iodum
Jod
Jood
Tincture iodine
50Diuretics, Potassium SparingPhase 21827

Interventional clinical trials:

(show all 47)
idNameStatusNCT IDPhase
1Efficacy and Safety of a Covered Self-expandable Dual-layered Metallic Mesh Stent (UVENTA) in Ureteral ObstructionUnknown statusNCT01788865Phase 4
2Functional MR UrographyCompletedNCT00301470Phase 4
3Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral StonesCompletedNCT01533389Phase 4
4Recovery Following Desflurane Versus Sevoflurane for Outpatient Urologic Surgery in Elderly FemalesCompletedNCT01310582Phase 4
5Ureteral Stent-related Pain and Mirabegron (SPAM) TrialRecruitingNCT02095665Phase 4
6Treatment of Symptoms After Stent Placement for Urinary Tract ObstructionActive, not recruitingNCT01741454Phase 4
7Clinical Study of the Aorta-femoral Bypass and Hybrid Intervention and the Iliac Arteries With Stenting and Plasty of the Common Femoral Artery Effectiveness in Patients With the Iliac Segment and Femoral Artery Occlusive Disease (TASC C, D)Active, not recruitingNCT02580084Phase 4
8Evaluation of the Efficacy of Tamsulosin (Alpha Blockers) Compared to Phloroglucinol in Improving JJ Ureteral Stent Tolerance. A Randomized Controlled TrialCompletedNCT01061073Phase 3
9Radical Versus Simple Hysterectomy and Pelvic Node Dissection in Patients With Low-risk Early Stage Cervical Cancer (SHAPE)RecruitingNCT01658930Phase 3
10Use of Alfuzosin in Stone Treatment With ESWLWithdrawnNCT00388271Phase 3
11Comparison of Silicone-covered Metallic Ureteral Stent and Double-J Stent for Malignant Ureteral ObstructionUnknown statusNCT01823575Phase 2
12Tolerance and Effectiveness of Ureteral Stents MEMOKATH ® 051 in Chronic Strictures of the UreterCompletedNCT00790686Phase 2
13Assessment of Drug-eluting Ureteral Stent on Bacterial Adherence and Biofilm FormationCompletedNCT00250406Phase 2
14A Randomized Control Trial Comparing Single vs. Multiple Application of Lidocaine Analgesia Prior to Urethral Catheterization ProceduresCompletedNCT00142064Phase 2
15Randomized Controlled Trial of Cystocele Plication Risks ("CPR Trial"): A Pilot StudyCompletedNCT01197248Phase 2
16TRC105 in Adults With Advanced/Metastatic Urothelial CarcinomaCompletedNCT01328574Phase 2
17Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and PlatinumCompletedNCT01426126Phase 2
18Mirabegron as Medical Expulsive Therapy (MET) for Ureteral Stones and Ureteral Stent PainNot yet recruitingNCT02744430Phase 2
19Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial CancerRecruitingNCT02437370Phase 1
20Cabozantinib-s-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary TumorsRecruitingNCT02496208Phase 1
21The Correlation Between Renal Injury and Biomarkers in Pediatric Ureteropelvic Junction Obstruction PatientsUnknown statusNCT01711996
22Ureteropelvic Junction Obstruction in Early Childhood: Comparison of Surgical Therapy and Surveillance. A Prospective, Randomized, Controlled Multi-Center StudyUnknown statusNCT00444431
23A Prospective Comparison Between Ureteral Stent and Nephrostomy Tube for an Urgent Drainage of Obstructed KidneyUnknown statusNCT00739284
24Drainage of Malignant Extrinsic Ureteral Obstruction Using the Memokath Ureteral StentCompletedNCT00166361
25Urinary Biomarkers as Predictors on Renal Function in Congenital HydronephrosisCompletedNCT00568724
26Evaluating Ureteral Length Using Computed Tomography (CT)CompletedNCT01542593
27The Efficacy and Safety of Local Anesthetic Infusion With RopivacaineCompletedNCT00930046
28Dismembered Pyeloplasty With and Without After Coming StentCompletedNCT02138877
29Uretal Flow Assessment During Gynecological ProceduresCompletedNCT00453882
30Urinary Markers for Unilateral Kidney ObstructionCompletedNCT01979042
31Comparison of Two Position for Ultrasound Guided Lumbar Plexus and Sciatic Nerve BlockCompletedNCT00988234
32Clinical Significance of Supranormal Differential Renal Function in the Recovery of HydronephrosisCompletedNCT01839006
33Early Infancy Ureteral Reimplantation for Distal Ureteral ObstructionRecruitingNCT02419339
34Indwelling Double-J Ureteral Stent Versus Externalized Modified-Salle Stent for PyeloplastyRecruitingNCT02713633
35Multi-Center Comparison of Dual Lumen Versus Single Lumen UreteroscopesRecruitingNCT02123082
36Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent RemovalRecruitingNCT02140970
37Indwelling Stent Discoloration ProjectRecruitingNCT02007980
38Care of the Urothelial Cancer Patient and Prospective Procurement of Urothelial Cancer TissueRecruitingNCT02379429
39Laparoscopic Pyeloplasty Registry and DatabaseActive, not recruitingNCT00169650
40Diagnostic Relevance of Laser Confocal Microscopy for the Screening of Upper Urinary Tract TumorsActive, not recruitingNCT02276924
41UC-GENOME: Urothelial Cancer-GENOmic Analysis to iMprove Patient Outcomes and rEsearchActive, not recruitingNCT02643043
42Ureteral Reimplantation for the Treatment of Extrinsic Malignant Ureteral ObstructionEnrolling by invitationNCT02160652
43CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction SyndromeNot yet recruitingNCT02812212
44Percutaneous Nephrostomy Versus Stent In Sepsis TrialNot yet recruitingNCT02929160
45Comparison of Dynamic Contrast Enhanced CT and Diuretic Renogram in The Evaluation of UPJOTerminatedNCT00199472
46Study to Determine if There Are Specific Clinical Factors to Determine Stent EncrustationTerminatedNCT00581178
47Severe Pelvic Organ Prolapse and Post-Obstructive Diuresis (SOPPO) Pilot StudyWithdrawnNCT02060331

Search NIH Clinical Center for Ureteral Obstruction

Genetic Tests for Ureteral Obstruction

About this section

Anatomical Context for Ureteral Obstruction

About this section

MalaCards organs/tissues related to Ureteral Obstruction:

35
Kidney, Bone, Endothelial, Bone marrow, Monocytes, Colon, Prostate

Animal Models for Ureteral Obstruction or affiliated genes

About this section

MGI Mouse Phenotypes related to Ureteral Obstruction:

40 (show all 22)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053758.9AGTR1, AGTR2, NOS2, PTGS2, TGFB1, TP53
2MP:00053918.8BMP7, CTNNB1, IL10, NOS2, PTGS2, TGFB1
3MP:00053708.7CTNNB1, EPO, IL10, NOS2, PTGS2, TGFB1
4MP:00020067.9AGTR2, CTNNB1, IL10, NOS2, PTGS1, PTGS2
5MP:00053887.7BMP7, CTNNB1, EPO, IL10, NOS2, PTGS1
6MP:00053797.5AGTR2, BMP7, CTNNB1, IL10, NOS2, PTGS1
7MP:00053817.3AGTR2, BMP7, CTNNB1, IL10, NOS2, PTGS1
8MP:00053697.1AGTR2, CLU, CTNNB1, EPO, IL10, NOS2
9MP:00053846.9AGTR2, CTNNB1, EPO, HSPB1, IL10, NOS2
10MP:00053906.9AGTR2, BMP6, BMP7, CTNNB1, IL10, NOS2
11MP:00107716.8AGTR2, AQP2, BMP7, CTNNB1, EPO, IL10
12MP:00036316.8AGTR1, AGTR2, BMP7, CLU, CTNNB1, IL10
13MP:00053896.7AQP2, BMP6, BMP7, CTNNB1, IL10, NOS2
14MP:00107686.5AGTR1, AGTR2, AQP2, BMP7, CTNNB1, EPO
15MP:00053676.4AGTR1, AGTR2, AQP2, BMP7, CLU, CTNNB1
16MP:00053866.3AGTR1, AGTR2, AQP2, BMP7, CLU, CTNNB1
17MP:00053976.2AGTR1, AQP2, BMP7, CTNNB1, EPO, HSPB1
18MP:00053875.9AGTR1, BMP7, CLU, CTNNB1, EPO, HSPB1
19MP:00053855.9AGTR1, AGTR2, BMP7, CLU, CTNNB1, EPO
20MP:00053785.7AGTR1, AGTR2, AQP2, BMP6, BMP7, CTNNB1
21MP:00053765.3AGTR1, AGTR2, AQP2, CLU, CTNNB1, EPO

Publications for Ureteral Obstruction

About this section

Articles related to Ureteral Obstruction:

(show top 50)    (show all 673)
idTitleAuthorsYear
1
Improving Comfort of Patients with Ureteral Obstruction and Malignant Disease Should Be of Concern. (27387032)
2016
2
The effect of aliskiren on the renal dysfunction following unilateral ureteral obstruction in the rat. (27570581)
2016
3
Ginsenoside-Rg1 inhibits endoplasmic reticulum stress-induced apoptosis after unilateral ureteral obstruction in rats. (25707520)
2015
4
Involvement of cytokines in the modulation and progression of renal fibrosis induced by unilateral ureteral obstruction in C57BL/6 mice: effects of thalidomide and dexamethasone. (26501392)
2015
5
Effect of L-arginine and L-NAME on Kidney Tissue Damage in Rats after 24 h of Bilateral Ureteral Obstruction. (26288704)
2015
6
Abdominopelvic actinomycosis in three different locations with invasion of the abdominal wall and ureteric obstruction: An uncommon presentation. (26001364)
2015
7
Quercetin attenuates cyclooxygenase-2 expression in response to acute ureteral obstruction. (25810437)
2015
8
Combination Therapy with Losartan and I+-Tocopherol in Acute Ureteral Obstruction-Induced Renal Excretory Dysfunction and Acidification Defect. (25031488)
2014
9
Effect of unilateral ureteral obstruction and anti-angiotensin II treatment on renal tubule cell apoptosis and interstitial fibrosis in rats. (25144992)
2014
10
ROS dependence of cyclooxygenase-2 induction in rats subjected to unilateral ureteral obstruction. (24226522)
2014
11
Ulinastatin inhibits unilateral ureteral obstruction-induced renal interstitial fibrosis in rats via transforming growth factor I^ (TGF-I^)/Smad signalling pathways. (23318600)
2013
12
Five-year experience with metallic stents for chronic ureteral obstruction. (23485505)
2013
13
The protective effects of metyrosine, lacidipine, clonidine, and moxonidine on kidney damage induced by unilateral ureteral obstruction in rats. (22202971)
2012
14
Gene expression changes induced by unilateral ureteral obstruction in mice. (22819101)
2012
15
Myeloid cell-derived hypoxia-inducible factor attenuates inflammation in unilateral ureteral obstruction-induced kidney injury. (22490864)
2012
16
Dermatan sulfate reduces monocyte chemoattractant protein 1 and TGF-I^ production, as well as macrophage recruitment and myofibroblast accumulation in mice with unilateral ureteral obstruction. (21833458)
2011
17
Vitamin E ameliorates renal fibrosis in ureteral obstruction: role of maintaining BMP-7 during epithelial-to-mesenchymal transition. (22619901)
2011
18
Editorial comment on: Ureteral obstruction: is the full metallic double-pigtail stent the way to go? (19232818)
2010
19
Fucosylated chondroitin sulfate attenuates renal fibrosis in animals submitted to unilateral ureteral obstruction: a P-selectin-mediated event? (20861075)
2010
20
Nephrocutaneous bypass in ureteral obstruction. (20156649)
2010
21
Renal uptakes of 99mTc-MAG3, 99mTc-DTPA, and 99mTc-DMSA in rabbits with unilateral ureteral obstruction. (20363984)
2010
22
Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression. (19530942)
2009
23
Long-term EGF treatment partially prevents reduction of renal blood flow in response to neonatally induced partial unilateral ureteral obstruction. (19142026)
2009
24
Angiotensin II regulates V2 receptor and pAQP2 during ureteral obstruction. (18971210)
2009
25
Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor. (18555228)
2008
26
Robotically assisted excision of ovarian vein for intermittent ureteral obstruction. (18435891)
2008
27
Protective effects of low-dose carbon monoxide against renal fibrosis induced by unilateral ureteral obstruction. (18094035)
2008
28
Re: Borin JF, Melamud O, Clayman RV. Initial experience with full-length metal stent to relieve malignant ureteral obstruction. J Endourol 2006;20:300-304. (18401884)
2008
29
Malignant extrinsic ureteral obstruction: a survey of urologists and medical oncologists regarding treatment patterns and preferences. (18372019)
2008
30
Metal stents for the management of malignant ureteral obstruction. (18811556)
2008
31
Acute renal papillary necrosis with complete bilateral ureteral obstruction in a child. (17382173)
2007
32
Myeloid sarcoma presenting with acute renal failure and bilateral ureteral obstruction: a case report and review of the literature. (17700206)
2007
33
Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. (17003824)
2006
34
Complete unilateral ureteral obstruction in the fetal lamb. Part II: Long-term outcomes of renal tissue development. (16516044)
2006
35
TGF-beta1 siRNA suppresses the tubulointerstitial fibrosis in the kidney of ureteral obstruction. (16443218)
2006
36
Apoptosis of circulating lymphocyte in rats with unilateral ureteral obstruction: role of angiotensin II. (16221096)
2005
37
An unusual cause of ureteral obstruction in a renal transplant recipient: ureteric aspergilloma. (15964354)
2005
38
The effect of partial unilateral ureteral obstruction release and allopurinol on the renal malondialdehyde and glutathione levels. (16351656)
2005
39
Images in clinical medicine. Ureteral obstruction in pregnancy. (15483272)
2004
40
Diagnosis of ureteral obstruction in patients with compromised renal function: the role of noninvasive imaging modalities. (15126809)
2004
41
An unusual cause of complete distal ureteral obstruction: giant fibroepithelial polyp. (15547846)
2004
42
Suppression of 15-hydroxyprostaglandin dehydrogenase messenger RNA concentration, protein expression, and enzymatic activity during human ureteral obstruction. (14718596)
2004
43
Late post-reimplantation ureteral obstruction during pregnancy: a transient phenomenon? (12913713)
2003
44
Anuria due to bilateral ureteral obstruction by Aspergillus flavus in an adult male. (11927329)
2002
45
Induction of p27KIP1 after unilateral ureteral obstruction is independent of angiotensin II. (11786086)
2002
46
Changes of renal cortical Na-K ATPase activity, protein, and mRNA expression in ureteral obstruction. (12355927)
2002
47
Partial unilateral ureteral obstruction in rats. (11948717)
2002
48
Lower pole ureteral obstruction secondary to fecal impaction in an 8-year-old girl. (11763494)
2001
49
An unusual cause of ureteral obstruction. (11696759)
2001
50
Ureteral obstruction due to retroperitoneal lymphatic cyst (cystic lymphangioma). (13655395)
1959

Variations for Ureteral Obstruction

About this section

Expression for genes affiliated with Ureteral Obstruction

About this section
Search GEO for disease gene expression data for Ureteral Obstruction.

Pathways for genes affiliated with Ureteral Obstruction

About this section

Pathways related to Ureteral Obstruction according to GeneCards Suite gene sharing:

(show all 22)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.8AGTR1, AGTR2, TGFB1
29.6AGTR1, EPO, IL10
39.6IL10, NOS2, TGFB1
49.5BMP6, BMP7, TGFB1
59.5BMP6, BMP7, TGFB1
69.4NOS2, PTGS2, TP53
79.4PTGS1, PTGS2
89.3CTNNB1, PTGS2, TGFB1, TP53
99.3BMP6, BMP7, CTNNB1, TGFB1
109.3BMP6, BMP7, CTNNB1, TGFB1
11
Show member pathways
9.3IL10, NOS2, PTGS2, TGFB1
129.1CTNNB1, PTGS1, PTGS2
139.0NOS2, PTGS1, PTGS2
149.0CTNNB1, NOS2, PTGS2, TGFB1, TP53
158.9HSPB1, IL10, NOS2, TGFB1
168.8HSPB1, NOS2, PTGS2, TP53
17
Show member pathways
8.8AGTR1, AGTR2, BMP6, BMP7, PTGS2, TGFB1
188.7AGTR1, CTNNB1, NOS2, PTGS2, TGFB1, TP53
198.2BMP6, BMP7, CTNNB1, HSPB1, TGFB1, TP53
20
Show member pathways
8.2CTNNB1, HSPB1, NOS2, PTGS1, PTGS2
21
Show member pathways
7.3AGTR1, AGTR2, BMP6, BMP7, EPO, HSPB1
22
Show member pathways
7.0BMP6, BMP7, EPO, IL10, NOS2, PTGS1

GO Terms for genes affiliated with Ureteral Obstruction

About this section

Cellular components related to Ureteral Obstruction according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular matrixGO:00310129.1BMP7, CLU, HSPB1, TGFB1
2cell surfaceGO:00099868.6CLU, EPO, SLC12A1, SLC9A3, TGFB1
3extracellular spaceGO:00056157.7BMP6, BMP7, CLU, EPO, HSPB1, IL10

Biological processes related to Ureteral Obstruction according to GeneCards Suite gene sharing:

(show all 41)
idNameGO IDScoreTop Affiliating Genes
1salivary gland morphogenesisGO:000743510.7BMP7, TGFB1
2renin-angiotensin regulation of aldosterone productionGO:000201810.7AGTR1, AGTR2
3positive regulation of cellular protein metabolic processGO:003227010.7AGTR1, TGFB1
4angiotensin-activated signaling pathwayGO:003816610.6AGTR1, AGTR2
5cellular response to insulin-like growth factor stimulusGO:199031410.6CTNNB1, TGFB1
6negative regulation of cell cycleGO:004578610.4BMP7, PTGS2, TGFB1
7positive regulation of histone deacetylationGO:003106510.4TGFB1, TP53
8response to vitamin DGO:003328010.4BMP7, PTGS2, TGFB1
9negative regulation of blood vessel endothelial cell migrationGO:004353710.3AGTR2, TGFB1
10epithelial to mesenchymal transitionGO:000183710.3BMP7, CTNNB1, TGFB1
11positive regulation of SMAD protein import into nucleusGO:006039110.3BMP6, TGFB1
12positive regulation of endothelial cell differentiationGO:004560310.2BMP6, CTNNB1
13positive regulation of bone mineralizationGO:003050110.2BMP6, BMP7, TGFB1
14SMAD protein signal transductionGO:006039510.2BMP6, BMP7, TGFB1
15positive regulation of pathway-restricted SMAD protein phosphorylationGO:001086210.1BMP6, BMP7, TGFB1
16response to organic substanceGO:001003310.1IL10, PTGS2, TGFB1
17cyclooxygenase pathwayGO:001937110.1PTGS1, PTGS2
18prostaglandin biosynthetic processGO:000151610.0PTGS1, PTGS2
19positive regulation of osteoblast differentiationGO:004566910.0BMP6, BMP7, CTNNB1
20cellular response to growth factor stimulusGO:007136310.0CLU, CTNNB1, TGFB1
21negative regulation of norepinephrine secretionGO:001070010.0AGTR2, PTGS1
22prostaglandin metabolic processGO:000669310.0PTGS1, PTGS2
23kidney developmentGO:00018229.8AGTR1, BMP6, BMP7, CTNNB1
24positive regulation of nitric oxide biosynthetic processGO:00454299.8AGTR2, CLU, PTGS2
25cellular response to mechanical stimulusGO:00712609.8BMP6, CTNNB1, PTGS2, TGFB1
26response to estradiolGO:00323559.7BMP7, CTNNB1, PTGS2, TGFB1
27response to organonitrogen compoundGO:00102439.7AGTR2, PTGS1, PTGS2
28response to glucocorticoidGO:00513849.7BMP6, IL10, PTGS2, SLC9A3
29response to lipopolysaccharideGO:00324969.6EPO, IL10, NOS2, PTGS2
30positive regulation of neuron differentiationGO:00456669.5BMP6, BMP7, EPO
31response to activityGO:00148239.5BMP6, CTNNB1, IL10
32regulation of blood pressureGO:00082179.5AGTR2, PTGS1, PTGS2
33positive regulation of apoptotic processGO:00430659.4BMP7, CTNNB1, PTGS2, TGFB1, TP53
34regulation of apoptotic processGO:00429819.2BMP6, BMP7, CTNNB1, TGFB1, TP53
35negative regulation of cell proliferationGO:00082859.1BMP7, CTNNB1, PTGS2, TGFB1, TP53
36positive regulation of transcription, DNA-templatedGO:00458938.8AGTR2, BMP7, CTNNB1, EPO, IL10, TGFB1
37regulation of cell proliferationGO:00421278.6AGTR1, CTNNB1, NOS2, PTGS1, PTGS2, TGFB1
38positive regulation of transcription from RNA polymerase II promoterGO:00459448.5BMP6, BMP7, CTNNB1, IL10, TGFB1, TP53
39inflammatory responseGO:00069548.4AGTR2, BMP6, IL10, PTGS1, PTGS2, TGFB1
40agingGO:00075688.4CLU, EPO, IL10, PTGS1, TGFB1
41positive regulation of cell proliferationGO:00082848.3AGTR2, CLU, CTNNB1, EPO, PTGS2, TGFB1

Molecular functions related to Ureteral Obstruction according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1angiotensin type II receptor activityGO:000494510.6AGTR1, AGTR2
2BMP receptor bindingGO:007070010.2BMP6, BMP7
3transforming growth factor beta receptor bindingGO:000516010.0BMP6, BMP7, TGFB1
4prostaglandin-endoperoxide synthase activityGO:000466610.0PTGS1, PTGS2
5cytokine activityGO:00051259.2BMP6, BMP7, IL10, TGFB1
6growth factor activityGO:00080839.2BMP6, BMP7, IL10, TGFB1
7protein N-terminus bindingGO:00474859.0CLU, TGFB1, TP53

Sources for Ureteral Obstruction

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet